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Abstract: In recent years, the possibility of favorably influencing the cognitive trajectory through
promotion of lifestyle modifications has been increasingly investigated. In particular, the relationship
between nutritional habits and cognitive health has attracted special attention. The present review
is designed to retrieve and discuss recent evidence (published over the last 3 years) coming from
randomized controlled trials (RCTs) investigating the efficacy of nutritional interventions aimed
at improving cognitive functioning and/or preventing cognitive decline in non-demented older
individuals. A systematic review of literature was conducted, leading to the identification of 11 studies
of interest. Overall, most of the nutritional interventions tested by the selected RCTs were found
to produce statistically significant cognitive benefits (defined as improved neuropsychological test
scores). Nevertheless, the clinical meaningfulness of such findings was not adequately discussed and
appears controversial. In parallel, only 2 studies investigated between-group differences concerning
incident dementia and mild cognitive impairment cases, reporting conflicting results. Results of
the present review suggest that several dietary patterns and nutritional components may constitute
promising strategies in postponing, slowing, and preventing cognitive decline. However, supporting
evidence is overall weak and further studies are needed.
Keywords: dementia; cognitive disorders; preventive strategies; randomized controlled trials;
nutrition; diet
1. Introduction
The aging of our societies is leading to a dramatic increase in the prevalence of chronic conditions,
threatening the sustainability of our healthcare systems. In particular, dementia is being increasingly
recognized as a public health priority, given its enormous socioeconomic burdens in the absence of
effective treatments [1]. In this context, the adoption of preventive strategies against dementia has
repeatedly been solicited [2,3].
In the last decades, observational studies have indicated a wide range of potentially modifiable
risk factors for dementia that could constitute targets for preventive strategies [4]. This has promoted
a gradual shift of the scientific understanding of dementia from that of an unpreventable late-life
condition to that of a lifelong disease process resulting from the competition of multiple risk and
protective factors [5]. The most consistent evidence concerns vascular risk factors (e.g., hypertension,
diabetes, obesity), psychosocial factors (e.g., depression), lifestyle behaviors (e.g., low mental and
physical activity, smoking) [4,6]. High educational attainment and work complexity, social networking,
engagement in mentally stimulating activities, and regular physical exercise have instead shown
protective properties against dementia [4,6,7]. The promising epidemiological evidence suggesting
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a reduction of incident dementia [8] has been (at least partly) attributed to actions targeting
cardiovascular risk factors (also through a more effective and wider use of specific treatments such
as aspirin and lipid-lowering therapy) and increasing awareness. Based on these evidences, studies
testing the efficacy of multidimensional interventions against dementia, mostly based on lifestyle
modifications, have being increasingly designed and conducted [3].
In this scenario, a growing body of evidence has been focused on the association between
dietary habits and cognitive performance/dementia. A recent meta-analysis of available cohort
studies indicated that several dietary patterns and nutritional components (i.e., Mediterranean diet,
unsaturated fatty acids, antioxidants (such as vitamin E, vitamin C, and flavonoids, vitamin B))
are associated with a significantly reduced risk of dementia [9]. Furthermore, low concentrations
of vitamin D have been related with an increased risk of cognitive decline [9]. Such nutritional
components may exert their protective function in multiple and convergent ways. They have been
shown to down-regulate the main pathophysiological pathways and processes linked to development
of dementia (in particular, Alzheimer’s disease (AD)), including amyloid deposition, neurofibrillary
degeneration, synapse loss, inflammation, increased oxidative stress, defects in mitochondrial function
and cellular energy production, loss of vascular integrity, and neuronal injury [10]. Based on these
considerations, the possibility of favorably influencing the cognitive trajectory by promoting the
adoption of specific nutritional habits has been increasingly investigated.
Despite providing crucial information concerning risk profiles, observational studies reporting
associations between nutritional patterns and dementia present many limitations: the dietary
assessment usually completed only once before the outcome ascertainment; the heterogeneity of
scores used to define dietary conformity as well as the cognitive evaluation; and the relevant residual
confounding due to the major influence exerted by socioeconomic factors on nutritional habits [11,12].
To address these issues and advance in the field, multiple randomized controlled trials (RCT) testing
nutritional interventions aimed at enhancing cognitive functioning in older persons have started to
appear in the literature. Various nutritional compounds and dietary modifications (e.g., vitamins,
omega-3 fatty acids, ketogenic diet, antioxidants) have been found to improve cognitive performance
in patients diagnosed with dementia and AD [10].
In view of the growing interest on this topic, the aim of the present study is to provide a
comprehensive, updated review of the recent literature (published over the past 3 years) exploring the
relationship between nutrition and cognitive performance. In particular, we focused on RCTs exploring
the efficacy of nutritional interventions at improving cognitive functioning and/or preventing
dementia among non-demented (i.e., cognitively healthy or presenting mild cognitive disturbances)
older individuals.
2. Methods
2.1. Identification and Selection of Studies
The flowchart depicted in Figure 1 shows the process leading to the selection of the articles
of interest for the present review. We performed a Medline literature search of studies published
over the past 3 years (from 1 November 2012 to 31 December 2015) using the Medical Subject
Heading (MeSH) terms “Randomized Controlled Trial”, “Human” and “English” combined with the
following terms: (“diet*” OR “nutr*” OR “food” OR “aliment*”) AND (“cognit*” OR “dement*” OR
“Alzheimer” OR “memory”). References of considered studies were also reviewed to identify further
relevant publications. The identified articles were singularly evaluated according to the following
inclusion criteria:
(1) reporting results from RCTs;
(2) testing nutritional interventions;
(3) adopting at least one outcome measure assessing cognitive performance and/or dementia (or
mild cognitive impairment, MCI) incidence;
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(4) enrolling non-demented (i.e., cognitively healthy or presenting mild cognitive disturbances) older
persons; and
(5) recruiting individuals with a mean age ě55 years.
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Figure 1. Flow-chart of articles selection.
2.2. Data Extraction
For each study retained for the present review, Authors abstracted the following data: number of
participants, demographic characteristics of the samples, characteristics of adopted interventions (i.e.,
doses, duration), outcome measures (in particular, cognitive function modifications and/or incidence
of dementia or MCI), ma re ults and conclusions. Three Authors (Marco Canevelli, Flaminia
Lucchini and Federica Quarata) discussed the collected data and reached a consensus to resolve the
existing discrepancies.
3. Results
A total of 117 articl s were retrieve from the literature o identify studies f potential interest for
the present revie (Figure 1). After a prescreening based on titles and abstracts, 16 articles were fully
evaluated. Thus, 11 studies were finally selected [11,13–22]. The main reasons for articles’ exclusion
were the non-RCT design, and the age of the sampled populations (<55 years). It is noteworthy that
two of the included studies referred to the same study population (i.e., the PREDIMED-NAVARRA
study) [17,18]. We decided to retain both the studies as they described different analyses, performed in
different subgroups of participants. Table 1 provides an overview of the included studies for what
concerns the characteristics of participants, nutritional interventions, adopted cognitive outcomes, and
main findings.
Nutrients 2016, 8, 144 4 of 10
Table 1. Randomized controlled trials exploring the cognitive effects of nutritional interventions among non-demented older individuals published over the last
3 years.
Reference Study Sample Intervention(s) Duration Cognitive Outcome(s) Main Results
Alves et al. 2013 [13] n = 56 healthy older women(mean age 66.8 years)
(1) Creatine (20 g/day for 5 days, then 5 g/day)
(2) Creatine + strength training
(3) Placebo
(4) Placebo + strength training
24 weeks MMSE; Stroop test; TMT;Digit Span; Delayed recall test
Creatine supplementation
did not promote any
significant cognitive benefit
Bin Sayeed et al. 2013 [14] n = 40 healthy elderly males(mean age 55.8 years)
(1) Nigella sativa Linn. Seeds (1000 mg/day)
(2) Placebo 9 weeks
WMS; Digit Span; ROCF; LCT;
TMT; Stroop test; Logical
memory test
Significant improvement of
all the cognitive scores in the
Nigella sativa group
Brickman et al. 2014 [15]
n = 37 healthy, sedentary
older subjects (mean age
57.7 years)
(1) High flavanol intake (900 mg cocoa flavanols
and 138 mg of (´)-epicatechin/day) + exercise
(2) High flavanol intake
(3) Low flavanol intake (10 mg cocoa flavanols and
<2 mg (´)-epicatechin/day) + exercise
(4) Low flavanol intake
12 weeks ModBent task
A high-flavanol intervention
had a significant effect on
ModBent performance,
independent of exercise
Kean et al. 2015 [16] n = 37 healthy older subjects(mean age 66.7 years)
(1) High flavanone drink (305 mg/day)
(2) Low flavanone drink (37 mg/day) 8 weeks
CERAD; SWM; DSST; LM;
Go-NoGo; Letter Fluency;
Serial sevens; WMS
Significant improvement of
global cognitive function in
the high flavanone group
Màrtinez-Lapiscina et al.
2013 [17] *
n = 268 older subjects at high
vascular risk (mean age
74.1 years)
(1) MedDiet + EVOO (1 L/w)
(2) MedDiet + mixed nuts (30 g/day)
(3) Control diet (advice to reduce dietary fat)
6.5 years
MMSE; CDT; WMS; FAS; RAVLT;
ROCF; BNT; CDR; TMT; WAIS;
Digit span
Cognitive status
Significant improvement of
fluency and memory tasks in
MedDiet + EVOO group.
Reduced MCI incidence
Màrtinez-Lapiscina et al.
2013 [18]
n = 522 older subjects at high
vascular risk (mean age
67.4 years)
(1) MedDiet + EVOO (1 L/week)
(2) MedDiet + mixed nuts (30 g/day)
(3) Control diet (advice to reduce dietary fat)
6.5 years MMSE; CDT
Significant improvement of
cognitive performance in the
two MedDiet groups
Ngandu et al. 2015 [19]
n = 1260 older subjects at
high risk of cognitive decline
(mean age 69.3 years)
(1) Diet (Finnish Nutrition Recommendations) +
exercise + cognitive training + vascular
risk monitoring
(2) General health advice
2 years
Comprehensive
neuropsychological test battery
(CERAD)
Significant improvement of
global cognition, executive
functioning and
processing speed
Nilsson et al. 2012 [20] n = 40 healthy older subjects(mean age 63.3 years)
(1) Fish oil n-3 PUFA (3 g/day)
(2) Placebo 5 weeks
Working memory and selective
attention tests
n-3 PUFA intervention
significantly improved
working memory
Valls-Pedret et al. 2015
[11]
n = 447 cognitively healthy
older subjects (mean age
66.9 years)
(1) MedDiet + EVOO (1 L/week)
(2) MedDiet + mixed nuts (30 g/day)
(3) Control diet (advice to reduce dietary fat)
4.1 years
(median)
MMSE; WMS; RAVLT; WAIS;
CTT; FAS; Digit span
Cognitive status
Significant improvement of
all the cognitive functions in
the 2 MedDiet groups. No
difference in MCI incidence
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Table 1. Cont.
Reference Study Sample Intervention(s) Duration Cognitive Outcome(s) Main Results
van de Rest et al. 2014
[21]
n = 127 frail or pre-frail older
subjects (mean age 79 years)
(1) Protein (30 g/day)
(2) Protein + exercise
(3) Placebo
(4) Placebo + exercise
24 weeks
MMSE; TMT; Stroop test; WMS;
WLT; VFT; Reaction time tasks;
Digit span
Exercise training in
combination with protein
supplementation improved
information processing speed
van der Zwaluw et al.
2014 [22]
n = 65 frail or pre-frail older
subjects (mean age 79 years)
(1) Protein (30 g/day)
(2) Placebo 24 weeks
MMSE; TMT; Stroop test; WMS;
WLT; VFT; Reaction time tasks;
Digit span
Improvement of reaction
time in the protein
supplementation group
* The study reports results observed in a subgroup of the population enrolled in the study [18]. EVOO: extra virgin olive oil; MedDiet: Mediterranean diet; PUFA: polyunsaturated
fatty acids. Cognitive functions/domains assessed by the adopted cognitive tools and measures: Boston Naming Test (BNT): naming and animals fluency; Clinical Dementia Rating
(CDR): dementia severity; Consortium to Establish a Diagnosis of Alzheimer’s Disease (CERAD): comprehensive neuropsychological test battery; Clock Drawing Test (CDT): global
cognition; Color Trail Test (CTT): attention and visuomotor speed; Digit Span: working memory; Digit Symbol Substitution Test (DSST): working memory; FAS: semantic and
phonemic fluency; Go-NoGo: inhibition and sustained attention; Letter Cancellation Test (LCT): visual attention; Letter Memory Task (LM): executive functions; Mini Mental State
Examination (MMSE): global cognition; ModBent: object recognition; Rey Auditory Verbal Learning Test (RAVLT): immediate and delayed verbal memory; Rey-Osterrieth Complex
Figure (ROCF): immediate and delayed visual memory; Spatial Working Memory (SWM): spatial working memory; Stroop test: selective attention; Trail Making Test (TMT):attention
and executive functions; Verbal Fluency Test (VFT): semantic memory and language; Wechsler Adult Intelligence Scale (WAIS): executive functions; Wechsler Memory Scale (WMS):
episodic memory; Word Learning Test (WLT): immediate and delayed verbal memory.
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3.1. Study Samples
Overall, 2631 subjects were recruited and randomized in the retained studies, with sample sizes
widely ranging between 37 and 1260 participants. The weighted mean age of the enrolled individuals
was 68.7 (standard deviation, SD 7.6) years, varying between 55.8 and 79.0 years across studies.
Two RCTs were gender-restricted, recruiting only healthy older women [13] and healthy elderly male
volunteers [14], respectively. Five studies specifically targeted subjects at risk for diverse adverse
outcomes. In particular, two studies [21,22] enrolled pre-frail and frail participants according to the
Fried and colleagues’ operationalization of frailty [23]. Two studies focused on older individuals at
high vascular risk (i.e., presenting diabetes or ě3 vascular risk factors) [17,18]. Finally, one study [19]
recruited subjects at risk for cognitive decline, as indicated by high scores at a dementia risk index [24].
Noticeably, in two studies, the exclusion of participants already exhibiting an overt dementia was
not explicitly described [21,22]. Nevertheless, the high mean MMSE scores of the recruited samples
indicated a normal or just mildly impaired global cognitive performance.
3.2. Nutritional Interventions
In nearly one third of the retained RCTs, the nutritional intervention was delivered in the context
of a multidomain strategy including also strength training [13], resistance-type exercise [21,22], or,
more broadly, a combination of physical activity, cognitive training, and vascular risk monitoring [19].
Overall, eight different interventions were tested. Seven studies explored the efficacy of single, specific
dietary components such as creatine [13], flavanols [15,16], milk protein concentrates [21,22],
polyunsaturated fatty acids [20], and a herbal food substance (i.e., Nigella sativa Linn. or black
cumin) [14]. On the other hand, the remaining four RCTs assessed the cognitive benefits produced by
more complex dietary regimens, such as the Mediterranean diet (supplemented with extra virgin olive
oil or mixed nuts) [11,17,18] and a similar pattern developed in accordance to the Finnish Nutritional
recommendations [19]. The adherence to both of these diets was promoted through individual and
group counseling sessions (mostly leaded by nutritionists), providing practical information and
support for facilitating lifestyle and dietary changes. In the PREDIMED studies [11,17,18], written
material including descriptions of seasonal foods, shopping lists, weekly meal plans, and cooking
recipes was also provided. Similar recommendations were given to the participants of these three
studies: high consumption of vegetables, fruits, legumes and cereals, olive oil as the principal source
of monounsaturated fat, low intake of saturated fat, moderate intake of fish, low-to-moderate intake
of dairy products, low consumption of meat and poultry, and wine consumed in low-to-moderate
amounts. These three RCTs tested the cognitive efficacy of such nutritional strategies over the long
term, with the duration of the adopted interventions ranging between 2 and 6.5 years. The other
studies (testing single components) had instead a shorter duration (ranging between 5 and 24 weeks).
3.3. Cognitive Outcomes and Main Findings
Only three of the retained studies adopted the cognitive status of participants as outcome
variable, investigating the incidence of MCI and dementia after 6.5 [17,18] and 4.1 [11] years of
intervention (consisting in Mediterranean diet for both of the studies), respectively. Nevertheless, only
in two of them between-groups differences in the observed MCI/dementia incidence were specifically
investigated. In the first study [17], a lower incidence of MCI was observed among subjects randomized
to Mediterranean diet plus extra virgin olive oil compared to the control group (odds ratio, OR: 0.34;
95% CI: 0.12–0.97). In the other study [11], the occurrence of MCI was found to be similar in the two
randomization groups. No significant between-group difference concerning incident dementia cases
was noticed in both studies.
The other RCTs adopted diverse neuropsychological measures and tools as primary outcomes,
thus assessing pre-post intervention modifications of cognitive scores. Most of these studies used
comprehensive, standardized batteries, consisting of various tests specifically targeting memory
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(both verbal and visual), attention and executive functions, visuo-spatial abilities, processing speed,
and language skills. Only one study exclusively focused on a single cognitive aspect, that is object
recognition [15]. Overall, nearly all the tested interventions were found to be effective at improving
the targeted neuropsychological functions, resulting in a significant improvement of global cognitive
functioning, memory tasks, language skills, executive functioning, and processing speed. Consistently,
post-hoc analyses of the FINGER study showed that the risk of overall and domain-specific (i.e.,
executive functions and processing speed) cognitive decline was higher in the control group than in
the intervention group [19]. One study reported negative findings from creatine supplementation [13].
4. Discussion
The present review was aimed at retrieving and discussing recent evidence from RCTs
investigating the efficacy of nutritional interventions in improving cognitive functioning and/or
preventing cognitive decline among non-demented older individuals.
A growing interest has been recently attracted by the possible relationship existing between
nutrition and cognitive health, leading to the design and conduction of several interventional studies.
Nevertheless, the evidence suggesting a potential preventive effectiveness of nutritional strategies
towards cognitive disorders is still scarce. Only two out of the eleven retained studies [11,17] provided
data concerning the possibility of actually preventing/delaying cognitive disorders among older
individuals by implementing a nutritional intervention (i.e., Mediterranean diet). These RCTs also
produced somehow conflicting results, being the MCI incidence found to be lower in the treatment
group in one study [17], while similar in the treatment and control groups in the other one [11].
Moreover, no significant difference concerning incident dementia cases was observed in the two
studies. The paucity of evidence on this topic, as well as the disproportion between observational
and experimental data in the field, is likely to be referred to the difficulty in performing preventive
RCTs against cognitive disorders (and more generally, against age-related pathological conditions [25]).
Several methodological issues (e.g., difficulty at selecting the target population, the precarious balance
between optimal timing of the intervention and incidence of the primary outcome, and the need of
long follow-up and large sample sizes [26]) have been frequently encountered in the conduction of
such researches resulting, to date, in an almost complete lack of substantial evidence about dementia
prevention. It is noteworthy that additional useful information might be shortly provided by ongoing
international RCTs testing the cognitive efficacy of multidomain, long-lasting interventions (including
also diet and nutritional advices) [19,27,28].
Most of the selected studies considered the changes in cognitive and neuropsychological
performance as primary outcome. In most of cases, the tested interventions produced a statistically
significant improvement of cognitive measures. These findings appear to be mostly confirmatory
of available evidence coming from observational studies, indicating that the exposition to
specific nutritional compounds (e.g., flavonoids, unsaturated fatty acids) or dietary patterns (e.g.,
Mediterranean diet) may result in cognitive benefits [9]. Nevertheless, the clinical meaningfulness of
such results was not at all discussed. None of the retained articles explicitly questioned if the measured
cognitive benefits (in terms of improved cognitive scores) could have been actually responsible for
a real clinical benefit (in terms of personal wellbeing and functioning). Given the challenges in
adopting “hard outcomes” (such as dementia incidence) in preventive trials, the use of composite
scores including several validated cognitive tests has been recommended [29]. Nevertheless, the
clinical significance of the observed cognitive changes still needs to be clarified [26]. This aspect
appears to be particularly challenging when healthy or mildly impaired participants are recruited.
Findings from selected RCTs, beside the ambiguous personal and clinical relevance, may be thus more
appropriately interpreted in a public health context, in which small long-term effects on common
disorders could have high relevance [26].
Interestingly, several studies included in the present review focused on individuals at risk of
cognitive decline and dementia (being frail or at high vascular risk, or exhibiting high scores at
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dementia risk scores). Moreover, in nearly half of these studies, the tested nutritional interventions
were part of broader strategies simultaneously targeting various domains of the older person (i.e.,
physical and mental activity, vascular care). These two approaches (i.e., the identification of at-risk
populations and the realization of multidomain interventions) have been repeatedly advocated in
the field of dementia prevention [26]. Restricting the focus on those individuals that are more likely
to develop dementia could increase the statistical power (thus allowing smaller sample size) and
avoid unnecessary interventions in subjects at low risk. In parallel, the adoption of multi-component
interventions (despite rendering difficult to determine which of the targeted components is responsible
for the observed benefit) could consent to more properly target the diverse factors contributing to
overall dementia risk.
Another aspect potentially limiting the implementation of dementia preventive strategies is
represented by their feasibility in the “real world”. None of the selected studies provided detailed
information concerning the transferability (e.g., in terms of costs, resources, potential socio-cultural
barriers) of the experimental interventions. At the same time, it should be noticed that nutritional
actions relying on healthy dietary patterns (such as the Mediterranean diet and similar regimens) have
already been shown to be cost-effective and easy-to-implement [30]. These aspects, combined with
the observed benefits produced by such nutritional strategies, are contributing to a gradual shift in
nutritional epidemiology from a “single nutrient” approach to a “whole diet” paradigm, more broadly
aimed at capturing the cumulative effects of the overall diet on the health status of the individual [12].
5. Conclusions
The possibility of postponing or preventing dementia through nutritional and dietary habits has
been increasingly investigated. In line with available epidemiological evidence, several nutritional
compounds and regimens have shown to produce significant cognitive benefits among older persons
enrolled in placebo-controlled studies. Nevertheless, despite these encouraging findings, robust
supportive evidence is still lacking. In particular, further RCTs with long follow-up are needed in
order to determine whether specific nutritional components or patterns may reduce the occurrence
of cognitive disorders and overt dementing illnesses. In parallel, the clinical meaningfulness of the
observed cognitive benefits, as measured by neuropsychological score changes, should be properly
addressed and discussed.
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